Home
About
Publications Trends
Recent Publications
Expert Search
Archive
know your legislators
What Resources Are Available to Help You Advocate?
Several organizations provide resources and support for advocating on cancer issues. Here are a few:
-
American Cancer Society
:
Offers advocacy toolkits and training.
-
Cancer Support Community
:
Provides resources for policy advocacy.
-
National Coalition for Cancer Survivorship
:
Focuses on legislative advocacy for cancer survivors.
-
Fight Colorectal Cancer
:
Provides tools for grassroots advocacy.
Frequently asked queries:
Why Should You Know Your Legislators?
How Can Legislators Impact Cancer Research and Funding?
What Questions Should You Ask Your Legislators?
How Do You Contact Your Legislators?
How Can You Prepare for a Meeting with Your Legislators?
What Resources Are Available to Help You Advocate?
What Materials are Commonly Used in Cancer Treatments?
Are there resistance issues with antifungal medications?
What are the Emotional Costs of Cancer?
What types of cancers are common in Fanconi Anemia patients?
What Types of Meditation are Effective for Cancer Patients?
What Role Do Policy and Regulation Play?
How are Deletions Detected in Cancer Research?
What Are the Benefits of Robotic-Assisted Surgery?
What Are the Key Treatment Approaches at St. Jude?
How Is IORT Administered?
What is the Prognosis for Cancer Patients with Endocrinopathies?
How do HER3 and HER4 function in normal cells?
Are There Alternatives to Rituximab?
How is Gastric Carcinoma Diagnosed?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Lung Cancer
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
Keratinocyte
Lipid-based nanoparticles
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
Tuberculosis
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe